Close Menu
    GCC TelegraphGCC Telegraph
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    GCC TelegraphGCC Telegraph
    Home » Maypharm’s Hyalmass filler with Hybrid Technology obtained CE to hit Europe and America’s market
    PR Newswire

    Maypharm’s Hyalmass filler with Hybrid Technology obtained CE to hit Europe and America’s market

    April 18, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    SEOUL, South Korea and NEW YORK, April 18, 2023 /PRNewswire/ — Being already popular on South Asia market, particularly in Vietnam, Philippines, Thailand, China, for Hybrid Technology and highly dense HA for long-lasting effect, Hyalmass filler obtains CE to properly enter Europe, America etc markets.

    Along with Metoo fill, Sedy fill, Metox, Mennus, Hairna and Eyebella, Hyalmass has passed a ton of exacting clinical preliminaries to guarantee device’s performance. It was developed by adding a local anaesthetic lidocaine to lessen pain during the procedure. It also contains a soft tissue material hyaluronic acid and aimed at temporary improvement of wrinkles. Hyalmass is made of a homogenized hyaluronic acid, which is Maypharm’s own product that creates a high bio-compatibility rate.

    Hyalmass is a cosmetic treatment that aims to restore volume and smooth out wrinkles in the face. This procedure is performed using hyaluronic acid, a naturally occurring substance in the body that provides hydration and fullness to the skin.

    Unique push rod of Hyalmass was designed to enable the user to insert it for the procedure with less effort. The handle design is specially developed to fit various sizes of hands and prevent from slipping.

    Maypharm’s Hyalmass filler

    Main benefit of using Hyalmass filler is immediate and noticeable results. After the treatment, patients can expect to see an improvement in the appearance of wrinkles, fine lines, and sagging skin, as well as an increase in overall facial volume. The results can last for up to 12 months and the treatment is safe and effective for most people.

    In addition to its cosmetic benefits, the Hyalmass filler can also have a positive impact on a person’s confidence and self-esteem. By restoring volume and smoothing out wrinkles, patients can feel more youthful and refreshed, which can lead to an improvement in their overall well-being.

    In conclusion, Hyalmass filler is a popular cosmetic treatment that offers a simple and effective solution for restoring volume and smoothing out wrinkles in the face. Whether you look forward to improving your appearance or boosting your confidence, this treatment is the best option to consider.

    Maypharm is looking forward to becoming well-known manufacturer of dermal fillers for their safety and efficiency, and being on highest demand on every market, Asia, Middle East and Africa or South and North America.

    Maypharm’s Hyalmass filler

    Visit the website for detailed information: http://www.maypharm.net

    Photo – https://mma.prnewswire.com/media/2056663/Maypharm_s_Hyalmass_filler.jpg
    Photo – https://mma.prnewswire.com/media/2056664/Maypharm_s_Hyalmass_filler.jpg

    Cision View original content:https://www.prnewswire.co.uk/news-releases/maypharms-hyalmass-filler-with-hybrid-technology-obtained-ce-to-hit-europe-and-americas-market-301800102.html

    Related Posts

    Armaf Unveils ‘Soda Pop’, a New Gourmand Fragrance from the Odyssey Collection

    May 25, 2026

    Gorenje Introduces the G800 Built-In Oven, Bringing More Space, Smarter Cooking, and Summer-Ready Convenience to Middle Eastern Homes

    May 25, 2026

    ZOE Energy Storage Partners with Local Saudi Ally to Build Kingdom’s First World-Class Battery Storage Manufacturing Base

    May 25, 2026

    Sentire® Surgical System Receives CE Mark (MDR) Approval, Cornerstone Robotics Enters a New Era in its Global Expansion

    May 25, 2026

    From Pakistan to Shanghai: A CAR-T Journey Fighting Relapsed Lymphoma

    May 25, 2026

    Changan Automobile Announces Global Strategic Partnership with the Portugal National Football Team

    May 23, 2026
    Latest News

    Measles outbreak in Bangladesh passes 60,000 cases

    May 23, 2026

    Bangladesh’s measles outbreak has passed 60,000 suspected cases, with confirmed and suspected child deaths nearing 500.

    PM Modi and Meloni spotlight deepening India-Italy ties

    May 21, 2026

    UAE and Germany review strategic ties in Berlin

    May 21, 2026

    South Korea launches $665.5 million industrial growth fund

    May 20, 2026

    Etihad expands Paris route with double daily A380 flights

    May 20, 2026

    Japan and South Korea launch energy security framework

    May 20, 2026

    GME posts strongest trading week in two decades

    May 19, 2026

    Porsche reveals bespoke 911 GT3 RS in Macadamiametallic

    May 18, 2026
    © 2026 GCC Telegraph | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.